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Abstract
Background: In 2010, Rwanda adopted ART for prevention of mother to child transmission of HIV from pregnant
women living with HIV during pregnancy and breasfeeding period. This study examines rates of mother-to-child-
transmission of HIV at 6–10 weeks postpartum and risk factors for mother-to-child transmission of HIV (MTCT)
among HIV infected women on ART during pregnancy and breastfeeding.
Methods: A cross-sectional survey study was conducted between July 2011–June 2012 among HIV-exposed infants
aged 6–10 weeks and their mothers/caregivers. Stratified multi-stage, probability proportional to size and systematic
sampling to select a national representative sample of clients. Consenting mothers/caregivers were interviewed on
demographic and program interventions. Dry blood spots from HIV-exposed infants were collected for HIV testing
using DNA PCR technique. Results are weighted for sample realization. Univariable analysis of socio-demographic
and programmatic determinants of early mother-to-child transmission of HIV was conducted. Variables were
retained for final multivariable models if they were either at least of marginal significance (p-value < 0.10) or played
a confounding role (the variable had a noticeable impact > 10% change on the effect estimate).
Results: The study sample was 1639 infants with HIV test results. Twenty-six infants were diagnosed HIV-positive
translating to a weighted MTCT estimate of 1.58% (95% CI 1.05–2.37%). Coverage of most elimination of MTCT
(EMTCT) program interventions, was above 80, and 90.4% of mother-infant pairs received antiretroviral treatment or
prophylaxis. Maternal ART and infant antiretroviral prophylaxis (OR 0.01; 95%CI 0.001–0.17) and maternal age older
than 25 years were significantly protective (OR 0.33; 95%CI 0.14–0.78). No disclosure of HIV status, not testing for
syphilis during pregnancy and preterm birth were significant risk factors for MTCT. Factors suggesting higher socio-
demographic status (flush toilet, mother self-employed) were borderline risk factors for MTCT.
Conclusion: ART for all women during pregnancy and breastfeeding was associated with the estimated low MTCT
rate of 1.58%. Mothers who did not receive a full package of anti-retroviral therapy according to the Rwanda EMTCT
protocol, and young and single mothers were at higher risk of MTCT and should be targeted for support in
preventing HIV infection.
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Background
The global community has committed to the elimination
of mother-to-child transmission of HIV (EMTCT) by
2015 and keeping their mothers alive, with targets of <
5% transmission (< 2% for early postnatal) and antiretro-
viral therapy (ART) coverage of at least 90% [1–4] Meas-
uring impact of EMTCT programs is necessary to track
acheivements towards this goal.
Rwanda is located in Eastern Africa, with 10.5 million
inhabitants. HIV prevalence in 2017 was estimated at 3.1%
in the general population and 3.8% among women age
15–49 years. [5] The national EMTCT program started in
2001, and a national EMTCT scale-up plan (2007–2012)
articulated a strategy to deliver comprehensive EMTCT
interventions within maternal and child health services.
[6] The EMTCT program reached 87% of health facilities
by 2012. All services were generally provided in the same
health facility, though not necessarily in the same service
point within the facility.
In November 2010, Rwanda EMTCT program adopted
antiretroviral treatment (ART) for all pregnant and
breastfeeding women (2010 WHO recommendation Op-
tion B). [7] Starting April 2012, the EMTCT program
extended ART for all pregnant women beyond the
breastfeeding period to life-long therapy (also known as
Option B+). [7] From 2010 the EMTCT program in-
cluded infant antiretroviral prophylaxis from birth to age
4–6 weeks. Table 1 compares Option A, B and B+. [7]
Chi et.al. [8] reviewed updated literature in 2013 and
confirmed the benefits of of all three options, however
they note in their conclusion that “To better understand
the downstream impact of the Option B+ approach, ‘real
world’ program data are needed and must be carefully
evaluated.” [8, pg 129] This report provides ‘real world’
data from the early Rwanda experience using Option B/B+.
This is the first report from a nationally representative
study on the early (6–10 postnatal weeks) effectiveness of
universal (Option B or B+) perinatal maternal ART on
mother-to-child transmission of HIV to measure progress
towards EMTCT targets in sub-Saharan Africa. The only
other published national early EMTCT effectiveness studies
have been from South Africa, [9, 10] which were done
when South Africa was using WHO Option A and showed
a 6 week transmission of 3.5% [7]. Other published early ef-
fectiveness studies of Option B or B+ have been only re-
gional, not national studies with 10% MTCT found in
Kenya [11] and 6.7% in Zimbabwe. [12, 13] Finally, one
paper has been published on the national 18-month effect-
iveness of the Zimbabwe EMTCT program during the
transition from Option A to Option B. [14] Therefore, this
study adds substantially to the current available literature
on national effectiveness of Option B or B+ at 6–10 postna-
tal weeks.
Study objectives
The study objectives were to: i) to measure rates of early
mother-to-child transmission (MTCT) of HIV at 6-weeks
postpartum; ii) to estimate coverage of key EMTCT inter-
ventions and services (e.g. HIV testing, CD4 cell count
testing, infant antiretroviral prophylaxis, counselling on
infant feeding); iii) to estimate the association between
MTCT rate and ART regimen, maternal background char-
acteristics including CD4 cell count, maternal health care
services and maternal and infant health status.
Methods
A cross-sectional facility-based survey was conducted
amongst mother/caregiver-infant pairs attending their
1st Diptheria-Tetanus-Pertussis (DTP1) immunization at
six weeks postnatal. This study was conducted in public
and faith-based primary health care facilities offering im-
munizations in all four Rwanda provinces and Kigali
City. Health centers with and without an EMTCT pro-
gram were selected in order to determine the national
maternal and child HIV transmission rate. Routine data
showed DTP1 coverage was 98.8%. [15] Facilities with
high immunization coverage have been recognized for
providing unique opportunities for cost-effectively meas-
uring EMTCT program impact on early MTCT for
EMTCT program evaluation. [16, 17] This methodology
was first used by Rollins [18] and colleagues, and later
was proven to be effective for measuring MTCT in
South African. [9], The Rwanda EMTCT Evaluation
protocol was adapted from the South African EMTCT
Table 1 Comparison of PMTCT Options A, B and B+ [7, 8]
Timing Option A Option B Option B+
Mother Baby Mother Baby Mother Baby
Antepartum ZDV from 14 weeks
onward
Three drug ARV combination
from 14 weeks until end of
breastfeeding
Three drug ARV combination
(from 1st HIV+ test) for life
Intrapartum Single-dose NVP
Postpartum 1 week ZDV + 3TC NVP for 6 weeks
or until end of
breastfeeding
NVP or ZDV until
6 weeks
NVP or ZDV until
6 weeks
ZDV zidovudine, NVP nevirapine, 3TC, lamiduvine, ARV antiretroviral
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Evaluation protocol and approved by the National Insti-
tute of Statistics of Rwanda and by Rwanda’s National
Ethics Committee.
Sample
Participants had to meet the following inclusion criteria:
six-to-ten week old infants attending clinic for DPT1
immunization; written informed consent obtained from
mother/caregiver; and mother known to be HIV-positive
through self reporting, Mother Card or tested HIV-
positive during DTP1 visit. For mothers who refused HIV
testing, were dead or absent, but mother/guardian con-
sented for the participation of the infant Dry Blood Spot
(DBS) ELISA was performed to identify infant HIV expos-
ure. The following were exclusion criteria: infants of
mothers known HIV-negative with known HIV-negative
partner; infants of mothers who tested HIV-negative to
rapid test during the study; severely ill infants needing
emergency medical care or urgent referral (e.g. severe
vomiting, convulsions, lethargic or unconscious, or severe
pneumonia or dehydration) (Fig. 1).
To determine the sample size for each health facility
type, expected MTCT rates were calculated based on
routine service delivery data for antenatal prevalence
and coverage of EMTCT antiretroviral prophylaxis. Esti-
mates of transmission rates for dual-therapy and no
treatment are taken from routine service delivery data
and previous findings on effectiveness of EMTCT in
Rwanda at 18 months (best available data prior to this
study) [19, 20].
For EMTCT facilities early (6–10 week) transmission
was estimated as 8%, with precision of 2% required. For
Non-EMTCT facilties early transmission was estimated
as 25%, with 5% precision. A design effect of two was
used to estimate sample size.
The median number of children immunised in the
preceding 12 months from routine service delivery data
was used to estimate expected number of children that
could be recruited from a facility during the planned
study duration. This was averaged for each stratum. The
nonresponse rate considered was 5%. This information
was used to calculate the number of facilities to be sam-
pled to deliver the planned sample size of 2042 children
(1412 in EMTCT Health Facilities and 630 in Non-
EMTCT Health Facilities).
Sample size required in EMTCT health facilities were
allocated proportionally (population proportionate-to-
size) across strata (rural versus urban) based on observed
2009 strata immunization totals.
The primary sampling units were public health facilities
and faith-based health facilities reportedly administering
DTP1 doses in the Rwanda vaccination program report.
While other public facilities do administer immunizations,
primary level health facilities are the main locations for
routine child health services. Data from the 2009 routine
service delivery report [21] and the Health Information
System database from the Ministry of Health were used to
Fig. 1 Testing and Enrollment Algorithm
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obtain the final sampling frame. The study was planned
for data collection in 161 out of 412 (39%) primary health
facilities over a period of seven months. Due to the small
number of non-EMTCT health facilities available at study
initiation (n = 36), all non-EMTCT health facilities were
sampled.
Data collection
Health facility nurses providing routine care were trained
to recruit mothers/caregivers during immunization days.
The nurses introduced the study and signed informed
consent was obtained from each eligible mother/caregiver.
Data for the survey were gathered using a question-
naire. Several validated previously field-tested question-
naires were adapted. [9, 18] The questionnaire gathered
information on maternal age, parity, socio-economic sta-
tus (living arrangements; income), antenatal care (num-
ber of visits, gestation at first booking, HIV testing
history; receipt of HIV test results; mother HIV test re-
sults; received EMTCT care during pregnancy and deliv-
ery; received infant feeding counseling; EMTCT
prophylaxis taken (what and when); HIV-related care
(CD4 count; on ART); birth information (birth weight;
gestation; delivery type) and feeding practices during the
past seven days. The questionnaire also documented
current infant weight, immunizations, postnatal visits
and illness since birth. The questionnaire was translated
into Kinyarwanda (Rwanda national language). The
questionnaire was tested in EMTCT sites not included
in the study sample to test question flow and under-
standing by participants. Adjustments were made after
the pilot (no significant changes necessary).
Trained health care providers collected blood samples.
For mothers whose HIV status was unknown by the time
of the study, blood samples were taken from consenting
mothers and tested at the health center using Rwanda
HIV rapid testing algorithm. Dry blood spot (DBS) from
HIV-exposed children were tested for HIV using DNA
PCR at the National Reference Laboratory of Rwanda.
The National Reference Laboratory reported results back
to the health facilities and the School of Public Health
research team. The quality of the data collection process
was checked on daily basis by nursing supervisors,
trained laboratory staff and School of Public Health re-
search team. Data entry, cleaning and validation was
performed using EPIDATA and analysed using STATA
SE 12.1.
Data analysis
Formal survey analysis included the specification of the
sampling stages and the finite number of primary sam-
pling units involved. A weighted analysis was performed
for Urban and Rural areas, as well as estimating the
national prevalence. The final weights were calculated in
3 phases:
– Calculation of the Weight was based on the inclusion
probability of a Health Facility: proportionate to the
number of 1st DTP of the Health facility by Stratum
– Calculation of the Weight based on the Sample
realization: number of observed (DBS taken and
interview done)/number of expected
– Combination (multiply) of the two weights for the
calculation of the final weight
– Truncation of the weight: every weight higher than
25 was rounded to 25.
For non-EMTCT health facilities, a weight of 1 was
used since all of them were part of the study. All esti-
mates are reported with 95% confidence limits.
Basic frequencies and 95% confidence intervals were
used for descriptive analysis. All results are adjusted for
clustering effects and weighted as appropriate for pro-
portionate sampling methodology. Denominators for es-
timates are from those with reported data, missing not
included.
Tests for association were carried out using chi-square
tests or Fishers Exact tests. All results were adjusted for
clustering. Multiple binary logistic regression analysis of
predictors of HIV transmission at 6 weeks was conducted.
Socio-demographic, health care services, EMTCT services
and disease severity variables were examined as potential
determinants of MTCT. Variables were retained for final
multivariable models if they were either at least of mar-
ginal significance (p-value < 0.10) or played a confounding
role (the variable had a noticeable impact > 10% change
on the effect estimate).
Results
Data collection was from July 2011 to June 2012. The
sample realized was 1639 (82% of desired sample size).
There was slightly lower sample realisation for Rural
EMTCT facilities (892/1191, 75%), higher than expected
sample realization for Urban EMTCT (655/234, 280%)
and substantially lower sample realisation for Non-
EMTCT sites (92/575, 16%). The sampling frame was
adhered to for selected health facilities and allocated
time spent was completed according to protocol, but the
realization of participants was different from expected.
This differential in expected participants experienced
per strata was considered due to natural experience of
women accessing EMTCT and accounted for during
weighting at analysis stage.
A total of 22,305 infants were screened (using a combin-
ation of: maternal interview, maternal HIV rapid testing
for mothers who reported HIV status unknown, or
HIV-negative mother in a discordant couple relationship).
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2066 were identified as HIV-exposed infants and a DBS
sample taken. Of these, 1828 met enrollment eligibility
criteria, consented to study participation and were inter-
viewed. 189 DBS were rejected by the lab or had indeter-
minant results, leaving 1639 subjects with both interview
questionnaire completed and DNA PCR result available
for analysis (Fig. 2).
The average age of the mothers was 29.5 years (SE 0.17)
and the majority (72.5%) had primary school education.
The majority were married (31.3%) or cohabitating (47.9%).
The main building material of the floor was natural/other
(68.1%), source of drinking water was a public tap (49.2%),
use of a pit latrine (97.5%), and use of firewood/straw/
dung/other as primary cooking fuel (72.5%). Almost one in
five mothers (18.9%) reflected some food insecurity (i.e. ran
out of food in the past year) and the majority had fewer as-
sets (61.5% had 1–3 assets such as a radio, phone, etc.). Just
under half of the mothers were employed (47.2%). The ma-
jority (81.1%) were multiparas and half (50.0%) had planned
pregnancies.
Twenty-six infants were diagnosed HIV-positive on
DNA PCR. The overall weighted MTCT rate was 1.58%
(95% CI 1.05–2.38%). The rate was 1.28% (95%CI 0.71–
2.30%) in rural areas and 2.06% in urban areas (95%CI
1.17–3.60%). The difference between the two areas was
not statistically significant (p = 0.24).
Figure 3 shows results for EMTCT service indicators
coverage in HIV-positive mothers and HIV-exposed in-
fants. In all health centers, most of the key EMTCT in-
dicators such as HIV testing, CD4 count, and maternal
ART during pregnancy were above 90%. Referral to ART
clinic, disclosure of HIV status and infant feeding coun-
seling were below 90% but above 80%. 97.4% (95.8–98.4)
of infants received antiretroviral prophylaxis. 91.1%
(88.7–93.0) of HIV-positive mothers were on ART dur-
ing pregnancy and 90.4% (87.9–92.3) of both mothers
and infants received antiretroviral treatment/ prophy-
laxis per protocol. Exclusive breastfeeding in the last/
previous 7 days was 88.1% (85.6–90.3) and coverage of
maternal ART at six weeks was 85.6% (82.9–88.0).
In univariable analyses, socio-demographic factors sig-
nificantly increasing the risk of MTCT (Table 2) in-
cluded younger maternal age, marital status and having
a flush toilet. Cohabitating was a protective factor redu-
cing the risk of MTCT.
Multiple EMTCT and maternal and child health service
factors were significantly associated with MTCT risk
(Table 3) reflecting the impact of missed opportunities in
the EMTCT cascade even in the context of high EMTCT
service coverage. HIV-exposed infants of mothers who
were not referred to the ART clinic, or started ART during
pregnancy or after delivery compared to starting before
pregnancy, were risk factors for MTCT. HIV-exposed in-
fants whose mothers tested HIV-negative or were not
tested during pregnancy or not taking ART during preg-
nancy were at increased risk of MTCT, as was starting in-
fant antiretroviral prophylaxis after 72 h and incomplete
antiretroviral treatment/prophylaxis (lack of anitretrovirals
in either mother or baby or both), however these variables
did not reach statistical significance (p < 0.05). Lack of in-
fant feeding counseling or disclosure of HIV status also in-
creased MTCT risk. Late attendance at antenatal care
(3rd trimester) by the mother was a risk factor. Not testing
women for syphilis during antenatal care was a risk factor
for MTCT, but this variable did not reach statistical sig-
nificance (p < 0.05).
Three multivariate models were created to assess inde-
pendent effects on MTCT. Variables in univariable analysis
(Tables 2 and 3) with a p-value < 0.10 were included in the
first two multivariable models. The third model combined
significant variables from these intial two models for a final
model examining both socio-demographic and EMTCT
service factors. A backward step-wise approach was used
to generate the final model (Table 4). Due to concerns
about statistical power as a result of small number of
events (n = 26) and potential co-linearity between certain
variables (e.g. referral for maternal ART and receipt of ma-
ternal ART, measures of maternal and infant antiretroviral
treatment/prophylaxis) only the following variables were
included in the full model: Maternal HIV testing status;
Mother ART clinic referral; Infant Feeding Counseling;
HIV Status Disclosure; Late Antenatal Care – 3rd Trimes-
ter; Syphilis testing during pregnancy; Delivery attendant;
Preterm delivery; Both Mother and Baby getting antiretro-
viral treatment/prophylaxis; Timing of maternal ART initi-
ation; Timing of infant Nevirapine initiation.
A large number of risk factors remained significant in
the final model. Receipt of maternal ART and infant anti-
retroviral prophylaxis according to Rwanda EMTCT
protocol was a highly significant protective factor against
MTCT (OR 0.01; 95%CI 0.001–0.17), while variables sug-
gesting inadequate antiretroviral treatment/prophylaxis
Fig. 2 Study Profile
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were all significant risk factors (No referral for ART,
started of ART after delivery, and start of infant Nevira-
pine after 72 h). Maternal age older than 25 years was pro-
tective (OR 0.33; 95%CI 0.14–0.78). Factors suggesting
higher socio-demographic status were risk factors for
MTCT (flush toilet, mother self-employed (borderline sig-
nificant). No disclosure of HIV status, no syphilis testing
during pregnancy and preterm birth were also significant
risk factors.
Discussion
The Rwanda rate of early transmission of HIV from
mother-to-child of 1.58% (95% CI 1.05–2.38%) showed a
reduction from the 2.6% at 6 weeks reported by routine
service delivery data in 2008, though this earlier data
from the routine EID program may have reflected selec-
tion bias. [21] It also compares favourably to 3.5% docu-
mented in South Africa which was using a combination
of dual-therapy and maternal ART (WHO Option A).
[9] Compared to regional studies of Option B or B+, this
rate compares favorably to 10% MTCT found in Kenya
and 6.7% in Zimbabwe. [12, 13] The Rwanda national
target is 2% at 18 months.
The coverage in the EMTCT Cascade is seen to be high
with all indicators above 80% and many over 90%. (Fig. 3)
The primary indicator for EMTCT program coverage is
mothers who received ART during pregnancy, this showed
a coverage of 91.1%, which is just above the Rwanda 2012
national target of 90%. [6] When both mothers and infants
are considered 90.4% of mothers and babies received the
recommended antiretroviral treatment/prophylaxis. Over
90% coverage of recommended antiretroviral treatment/
prophylaxis during pregnancy is also consistent with
UNAIDS targets for global elimination of MTCT, however
the drop to 85.6% at 6–10 weeks is a concern as it is below
the UNAIDS target for ART during breastfeeding of 90%.
[10] The coverage figures for mothers and babies combined
compare favorably to other studies, such as 65% in
Zimbabwe, [13] 26% in rural Kenya, [11]. These figures
also suggest approximately 10% missed opportunities
for antiretroviral therapy/prophylaxis per Rwandan
protocol in mother-baby pairs. These missed opportun-
ities represented a significant risk for increased MTCT
(Table 4), which is consistent with other reports in the
literature [9–11].
Several socio-demographic factors showed in univari-
able analysis to increase MTCT risk, however, only flush
toilet and mother self-employed remained significant or
borderline significant, respectively, in final multivariable
analysis (Table 4). This finding suggests that higher
socio-economic mothers seem more at risk of MTCT.
Bucagu et al. [22] did not find any association of socio-
economic status to MTCT in one health center in
Rwanda, however this report was limited in scope and
size. While some studies suggest the poor face more bar-
riers to access EMTCT services [23, 24], the findings in
this study are consistent with findings from a Nigerian
study [25] which found that higher income mothers
were less likely to access EMTCT services. Further
studies on the relationship of socio-economic status,
utilization of EMTCT services and MTCT in Rwanda
are needed to allow better targeting of services across
populations.
Teen and young mothers (< 25 years old) also showed
a higher risk for mother-to-child transmission in the
final multivariable analyses. This result is consistent
with the Bucagu study which found a small but non-
significant increased risk for women age less than 24
[22] and is also consistent with the Nigeria study which
found a strong association between teenage mothers
and MTCT risk [25]. Younger mothers are theorized to
utilize EMTCT services less than older women [25] so
this issue is important in the context of the Rwandan
EMTCT program.
Fig. 3 Rwanda Elimination of Mother to Child Transmission Programme (EMTCT) Cascade
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Lack of disclosure of HIV status showed an almost
7-fold increase in MTCT in the multivariable analysis.
More than half (53–65%) of people in the Rwanda DHS
indicated an accepting attitude towards persons with
HIV/AIDS, [15] and a study of Rwandans with HIV
showed limited perceived discrimination [26]. However,
Table 2 Univariable Analysis of Infant HIV Infection by Socio-Demographic Factors
Variable Answer (#)* MTCT % 95%CI p-value
Infant sex Female (826) 1.8 1.1–3.0 0.462
Male (813) 1.4 0.8–2.3
Age of mother 35+ (399) 1.3 0.4–3.8 0.003
25–34 (809) 0.9 0.4–1.8
15–24 (360) 3.6 2.3–5.7
Education of mother None (273) 2.1 0.9–4.9 0.308
Primary (1145) 1.2 0.7–2.1
Secondary+ (183) 3.5 1.3–8.7
Marital status of mother Married (508) 2.5 1.1–5.5 0.046
Co-Habitating (797) 0.6 0.2–1.2
Single/Other (324) 1.9 1.1–3.2
Main building material of the floor Natural/Other (1629) 2.7 1.4–5.1 0.334
Rudimentary (152) 1.2 0.2–5.8
Finished (383) 1.3 0.7–2.2
Main source of drinking water Tap in House/Yard (154) 2.3 1.0–5.2 0.696
Public Tap (859) 1.6 0.9–2.8
Well (covered or uncovered) (469) 1.1 0.4–3.1
Spring/River/Other (146) 2.3 0.8–6.6
Type of toilet Flush (16) 10.2 2.2–36.6 0.004
Pit Latrine (1580) 1.5 1.0–2.4
None/Bush/Other (31) 0 –
Main source of cooking fuel Firewood/Dung/ Other (1133) 1.2 )0.7–2.1 0.071
Elec/Gas/Kerosene/ Charcoal (497) 2.7 1.6–4.5
Depletion of food in past 12 months Never ran out of food (1320) 1.9 0.8–4.3 0.717
Ran out of food (299) 1.5 0.9–2.5
Number of Pregnancies One (309) 2.3 1.2–4.4 0.312
2 or more (1295) 1.4 0.9–2.4
Planned Pregnancy Not Planned (767) 1.2 0.7–2.1 0.079
Planned (794) 2.0 1.2–3.3
Religion Catholic (662) 1.9 1.0–3.4 0.518
Other Christian (739) 1.3 0.7–2.3
Other Religion (223) 1.9 1.0–3.5
Rural or Urban Rural (984) 1.3 0.7–2.3 0.268
Urban (655) 2.1 1.2–3.6
Source of income (can indicate multiple sources) Self-Employed (744) 2.2 1.3–3.8 0.115
Other Source (970) 0.9 0.5–1.6
None (96) 1.5 0.3–7.3
Composite Asset Indicator (Electricity, Radio, TV, Phone,
Refrigerator, Bicycle, Motorcycle/Scooter, Car)
0 assets (507) 1.3 0.6–2.9 0.323
1–2-3 assets (1000) 1.5 0.8–2.7
4–5-6 assets (126) 3.5 1.7–7.5
*Totals may not add to 100% due to missing
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lack of disclosure and stigma may impact on both treat-
ment adherence and safe infant feeding. Stigma and
disclosure to family and friends of HIV status have
Table 3 Univariable Analysis of Infant HIV Infection by EMTCT
Service and Other Health System & Maternal/Infant indicators
Variable Answer (#)* MTCT % 95%CI p-value
EMTCT Site Yes (1547) 1.6 1.1–2.5 0.097





Yes (1516) 1.6 1.0–2.5 0.0504








Yes (1615) 1.6 1.0–2.4 0.6220




















CD4 done (1505) 1.6 1.0–2.4 0.432
CD4 not done (92) 2.7 1.07.4
Mother referred
to ART clinic
Yes referred (1316) 1.1 0.6–2.0 0.034
Not referred (242) 3.2 1.9–5.6
CD4 level > 350 (275) 2.2 1.1–4.5 0.328
<=350 (1075) 1.4 0.7–2.5
Mother visited
ART clinic
Yes (1467) 1.6 1.1–2.5 0.637





Yes (1474) 1.3 0.8–2.1 0.051


































Table 3 Univariable Analysis of Infant HIV Infection by EMTCT
Service and Other Health System & Maternal/Infant indicators
(Continued)
Variable Answer (#)* MTCT % 95%CI p-value
Infant
Cotrimoxazole
Yes (639) 1.1 0.5–2.7 0.217





Yes (1420) 1.1 0.6–2.0 0.024





in last 24 h
Yes (1439) 1.5 0.9–2.3 0.399
No (196) 2.4 1.0–5.7
Any Breastfeeding Yes (1429) 1.5 1.0–2.4 0.535
No (210) 2.1 0.9–5.1
Disclosed status Yes (1340) 1.1 0.7–1.9 0.006
Nov (252) 4.1 2.4–6.8
Perceived
Discrimination
Yes (212) 2.7 1.2–6.0 0.255
No (1372) 1.5 0.9–2.3















Yes (1264) 1.4 0.9–2.3 0.062




Yes (602) 1.9 1.0–3.6 0.458
No (952) 1.4 0.8–2.4
Place of Delivery Facility (1525) 1.5 0.9–2.2 0.257
Home/Other (98) 3.5 1.3–9.1
Method
of Delivery














Yes (85) 2.2 1.0–4.9 0.467
No (1533) 1.5 1.0–2.4
Preterm Yes (41) 3.5 1.3–9.4 0.349
No (1598) 1.5 1.0–2.4
*Totals may not add to 100% due to missing
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consistently been seen to impact EMTCT care and
treatment adherence in the literature [22, 26–29].
Two antenatal care variables were significant risk fac-
tors for MTCT, antenatal care started after 27 weeks
gestation and no maternal syphilis test during preg-
nancy. Not having a syphilis test remained significant in
the final model. This association was also seen in a
South African cohort study, which theorized that syph-
ilis testing may be a marker for quality of antenatal care
[30]. More recent policy analyses suggest the need for
integration across HIV and Syphillis elimination pro-
grams to improve antenatal quality of care [31]. Preterm
birth was a risk factor for MTCT which is consistent
with the literature [30].
Limitations of the current design must be recognized.
The data were facility-based using infants presenting for
immunization. In their 2012 publication ‘A short guide
on methods: measuring the impact of national EMTCT
programmes: towards the elimination of new HIV infec-
tions in children by 2015 and keeping their mothers
alive, WHO recognizes this methodology as one of sev-
eral available to assess EMTCT impact. [17] This docu-
ment notes the following pros and cons for this method:
“in settings with high immunization coverage, real time
data can be captured to inform population-level trans-
mission and early infant HIV infection; relatively quick
to undertake and can be repeated to provide trend data,
especially if a modest amount of additional data is col-
lected at the same time; also provides results for infants
of mothers who did not attend antenatal clinic or receive
EMTCT care; however this design misses children who
have died before immunization” [17,pg9].
In Rwanda the 6 week immunization visit has high at-
tendance nationally (98.8%) meeting the condition for
high immunisaiton coverage as suggested by WHO. In
addition, the socio-demographic factors in this study
were similar to those in the Rwanda DHS completed the
year prior to the study. [15] Identification and referral of
eligible infants to the clinic was also done during the
immunization outreach strategy program in villages to
maximize the chance of having all eligible infants. In-
fants who did not come for immunization, had severe
illness or had already died by 6 weeks of age were not
included in the sample suggesting a possible under-
estimation of prevalence. Also, there were differences in
the expected sample size per sampling strata (e.g. urban/
rural and EMTCT/Non-EMTCT). These differentials
may have existed as there were fewer Non-EMTCT sites
due to rapid EMTCT program scale-up, and clients may
have traveled to urban areas and EMTCT clinic sites in
expection of more comprehensive services. These differ-
ences across strata were accounted for by weighting dur-
ing statistical analyses. There is always potential for
recall bias, however the relatively short recall period of
6 weeks minimizes this potential bias. Social desirabil-
ity bias and fear of disclosure and stigma may cause
mothers to either over or under-report participation in
the EMTCT program. Confidentiality was assured and
discussed as part of the informed consent process and
a private place was secured for conducting interviews.
In addition, data collectors were routine clinic nurses
who had full access to maternal and newborn records
to identify possible HIV-exposed infants. Established
sensitivity and specificity of the HIV testing were oper-
ational, but should have been minimized through
proper handling of specimens and assurance of labora-
tory quality control. The study did not include a meas-
ure of daily adherence to ART only regimen. In
addition, national averages could hide subnational dis-
parities not addressed in this study and suggest a need
for further investigations on equity in the EMTCT
program.
Table 4 Final Multivariable Model examining socio-demographic and EMTCT service variables as predictors of MTCT
Variables Odds ratio Std Err. t Pr(T > t) 95% Confidence Interval
5.53 2.53 3.74 < 0.001 2.24 13.70
Mother timing of initiation of ART during pregnancy (Ref: 1=prior to pregnancy) 2.03 1.18 1.22 0.226 0.64 6.44
Mother timing of initiation of ART after delivery (Ref: 1=prior to pregnancy) 236.54 267.37 4,84 < 0.001 25.26 2213.05
No Disclosure (Ref: Disclosure) 6.19 1.87 6.05 < 0.001 3.41 11.24
Gestational Age started antenatal care > = 27 weeks (Ref:< 27 weeks) 1.65 0.73 1.12 0.264 0.68 3.97
No Syphilis Screen during pregnancy (Ref: Yes) 2.87 0.90 3.35 0.001 1.54 5.35
Full Term (Ref: Preterm) 0.24 0.09 −3.95 < 0.001 0.12 0.50
Infant ARV Prophylaxis Initiation within 6 weeks (Ref:Nevirapine within 72 h) 5.01 1.99 4.05 < 0.001 2.28 11.02
Both Mother & Baby got ART/ARV (Ref: either mother or baby or both no ART/ARV) 0.01 0.18 −3.40 0.001 0.001 0.17
Mother age > 25 (Ref: <=25 years old) 0.33 0.13 −2.54 0.012 0.14 0.78
Source of income Self-employed (Ref: None) 2.78 1.62 1.75 0.082 0.88 8.82
Type of toilet Pit (Ref: Flush) 0.12 0.07 −3.92 < 0.001 0.04 0.35
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Conclusions
The low rate of MTCT of 1.58% achieved in Rwanda is a
clear indication that new HIV infections in children can
reach elimination targets. To reduce the the MTCT rate
futher, the program must begin to address existing missed
opportunities, particularly with regard to coverage of ma-
ternal ART and infant antiretroviral prophylaxis. Integra-
tion of EMTCT within the maternal and child health care
platform [32], enhanced early treatment with ART and re-
tention in care, starting antenatal care early and continu-
ing antenatal care are some of the strategies to minimize
the risks of missed opportunities. In addition, young, sin-
gle mothers appear to be at higher risk suggesting the
need for targeting this population.
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